vs
Side-by-side financial comparison of CF Industries (CF) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
CF Industries is the larger business by last-quarter revenue ($1.9B vs $1.1B, roughly 1.7× PERRIGO Co plc). CF Industries runs the higher net margin — 26.4% vs -127.8%, a 154.2% gap on every dollar of revenue. On growth, CF Industries posted the faster year-over-year revenue change (22.8% vs -2.5%). CF Industries produced more free cash flow last quarter ($313.0M vs $148.6M). Over the past eight quarters, CF Industries's revenue compounded faster (12.8% CAGR vs 1.3%).
CF Industries Holdings, Inc. is an American manufacturer and distributor of agricultural fertilizers, including ammonia, urea, and ammonium nitrate products. The company is based in Northbrook, Illinois, a suburb of Chicago, and was founded in 1946 as the Central Farmers Fertilizer Company. For its first 56 years, it was a federation of regional agricultural supply cooperatives. CF then demutualized, and became a publicly traded company.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
CF vs PRGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.9B | $1.1B |
| Net Profit | $495.0M | $-1.4B |
| Gross Margin | 40.9% | 32.6% |
| Operating Margin | 33.0% | -116.0% |
| Net Margin | 26.4% | -127.8% |
| Revenue YoY | 22.8% | -2.5% |
| Net Profit YoY | 26.3% | -3093.9% |
| EPS (diluted) | $2.56 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.9B | $1.1B | ||
| Q3 25 | $1.7B | $1.0B | ||
| Q2 25 | $1.9B | $1.1B | ||
| Q1 25 | $1.7B | $1.0B | ||
| Q4 24 | $1.5B | $1.1B | ||
| Q3 24 | $1.4B | $1.1B | ||
| Q2 24 | $1.6B | $1.1B | ||
| Q1 24 | $1.5B | $1.1B |
| Q4 25 | $495.0M | $-1.4B | ||
| Q3 25 | $460.0M | $7.5M | ||
| Q2 25 | $492.0M | $-8.4M | ||
| Q1 25 | $351.0M | $-6.4M | ||
| Q4 24 | $392.0M | $-44.4M | ||
| Q3 24 | $341.0M | $-21.0M | ||
| Q2 24 | $506.0M | $-108.4M | ||
| Q1 24 | $238.0M | $2.0M |
| Q4 25 | 40.9% | 32.6% | ||
| Q3 25 | 38.1% | 36.1% | ||
| Q2 25 | 39.9% | 34.4% | ||
| Q1 25 | 34.4% | 37.6% | ||
| Q4 24 | 34.4% | 33.9% | ||
| Q3 24 | 32.4% | 37.2% | ||
| Q2 24 | 43.2% | 37.0% | ||
| Q1 24 | 27.8% | 33.1% |
| Q4 25 | 33.0% | -116.0% | ||
| Q3 25 | 35.0% | 7.0% | ||
| Q2 25 | 34.3% | 4.3% | ||
| Q1 25 | 27.4% | 4.5% | ||
| Q4 24 | 28.9% | 10.0% | ||
| Q3 24 | 26.6% | 7.4% | ||
| Q2 24 | 40.6% | -2.5% | ||
| Q1 24 | 20.6% | -5.1% |
| Q4 25 | 26.4% | -127.8% | ||
| Q3 25 | 27.7% | 0.7% | ||
| Q2 25 | 26.0% | -0.8% | ||
| Q1 25 | 21.1% | -0.6% | ||
| Q4 24 | 25.7% | -3.9% | ||
| Q3 24 | 24.9% | -1.9% | ||
| Q2 24 | 32.2% | -10.2% | ||
| Q1 24 | 16.2% | 0.2% |
| Q4 25 | $2.56 | $-10.23 | ||
| Q3 25 | $2.19 | $0.05 | ||
| Q2 25 | $2.37 | $-0.06 | ||
| Q1 25 | $1.85 | $-0.05 | ||
| Q4 24 | $1.86 | $-0.32 | ||
| Q3 24 | $1.55 | $-0.15 | ||
| Q2 24 | $2.30 | $-0.79 | ||
| Q1 24 | $1.03 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | $3.2B | — |
| Stockholders' EquityBook value | $4.8B | $2.9B |
| Total Assets | $14.1B | $8.5B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $432.1M | ||
| Q2 25 | — | $454.2M | ||
| Q1 25 | — | $409.9M | ||
| Q4 24 | — | $558.8M | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | — | $542.8M | ||
| Q1 24 | — | $658.5M |
| Q4 25 | $3.2B | — | ||
| Q3 25 | $3.0B | — | ||
| Q2 25 | $3.0B | — | ||
| Q1 25 | $3.0B | — | ||
| Q4 24 | $3.0B | — | ||
| Q3 24 | $3.0B | — | ||
| Q2 24 | $3.0B | — | ||
| Q1 24 | $3.0B | — |
| Q4 25 | $4.8B | $2.9B | ||
| Q3 25 | $4.8B | $4.4B | ||
| Q2 25 | $5.0B | $4.5B | ||
| Q1 25 | $4.8B | $4.4B | ||
| Q4 24 | $5.0B | $4.3B | ||
| Q3 24 | $5.2B | $4.6B | ||
| Q2 24 | $5.5B | $4.5B | ||
| Q1 24 | $5.4B | $4.7B |
| Q4 25 | $14.1B | $8.5B | ||
| Q3 25 | $14.2B | $10.1B | ||
| Q2 25 | $13.8B | $10.1B | ||
| Q1 25 | $13.3B | $9.8B | ||
| Q4 24 | $13.5B | $9.6B | ||
| Q3 24 | $13.8B | $11.2B | ||
| Q2 24 | $13.8B | $10.4B | ||
| Q1 24 | $13.9B | $10.6B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.61× | — | ||
| Q2 25 | 0.60× | — | ||
| Q1 25 | 0.62× | — | ||
| Q4 24 | 0.60× | — | ||
| Q3 24 | 0.57× | — | ||
| Q2 24 | 0.54× | — | ||
| Q1 24 | 0.55× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $539.0M | $175.4M |
| Free Cash FlowOCF − Capex | $313.0M | $148.6M |
| FCF MarginFCF / Revenue | 16.7% | 13.4% |
| Capex IntensityCapex / Revenue | 12.1% | 2.4% |
| Cash ConversionOCF / Net Profit | 1.09× | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.8B | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $539.0M | $175.4M | ||
| Q3 25 | $1.1B | $51.7M | ||
| Q2 25 | $563.0M | $75.9M | ||
| Q1 25 | $586.0M | $-64.5M | ||
| Q4 24 | $420.0M | $312.6M | ||
| Q3 24 | $931.0M | $42.2M | ||
| Q2 24 | $475.0M | $9.5M | ||
| Q1 24 | $445.0M | $-1.4M |
| Q4 25 | $313.0M | $148.6M | ||
| Q3 25 | $717.0M | $29.8M | ||
| Q2 25 | $318.0M | $56.7M | ||
| Q1 25 | $454.0M | $-90.0M | ||
| Q4 24 | $223.0M | $274.9M | ||
| Q3 24 | $792.0M | $15.1M | ||
| Q2 24 | $391.0M | $-18.9M | ||
| Q1 24 | $347.0M | $-26.5M |
| Q4 25 | 16.7% | 13.4% | ||
| Q3 25 | 43.2% | 2.9% | ||
| Q2 25 | 16.8% | 5.4% | ||
| Q1 25 | 27.3% | -8.6% | ||
| Q4 24 | 14.6% | 24.2% | ||
| Q3 24 | 57.8% | 1.4% | ||
| Q2 24 | 24.9% | -1.8% | ||
| Q1 24 | 23.6% | -2.4% |
| Q4 25 | 12.1% | 2.4% | ||
| Q3 25 | 20.9% | 2.1% | ||
| Q2 25 | 13.0% | 1.8% | ||
| Q1 25 | 7.9% | 2.4% | ||
| Q4 24 | 12.9% | 3.3% | ||
| Q3 24 | 10.1% | 2.5% | ||
| Q2 24 | 5.3% | 2.7% | ||
| Q1 24 | 6.7% | 2.3% |
| Q4 25 | 1.09× | — | ||
| Q3 25 | 2.31× | 6.89× | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 1.67× | — | ||
| Q4 24 | 1.07× | — | ||
| Q3 24 | 2.73× | — | ||
| Q2 24 | 0.94× | — | ||
| Q1 24 | 1.87× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CF
| Ammonia | $591.0M | 32% |
| UAN | $493.0M | 26% |
| Urea | $372.0M | 20% |
| Other | $244.0M | 13% |
| Other Products | $147.0M | 8% |
| Ammonium Nitrate Segment | $25.0M | 1% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
